drugset / Trial / NCT00418249

Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women

NCT00418249

Phase 2 Unknown 40 enrolled Rabin Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this study is to assess the safety and efficacy of topical AS101 as treatment for Female Androgenetic Alopecia (FAGA) in menopause women.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject TRICHLOROTELLURATE Small molecule Topical

Indications